DermTech: Mark Aguillard

DermTech has appointed Mark Aguillard its chief commercial officer, effective Sept. 19. He has more than 20 years of experience in developing and commercializing novel molecular diagnostics and was previously CCO of Epi Sciences. Before that he held commercial leadership roles at Myriad Genetics, Binx health, OmniSeq, and Eli Lilly.